The rare t(6;8)(q27;p11) translocation in a case of chronic myeloid neoplasm mimicking polycythemia vera

Leukemia and Lymphoma

Volumn 49, Issue 9, 2008, Pages 1832-1835

  Lourenco, Gustavo J ^a   Ortega, Manoela M ^a   Freitas, Leandro L L ^a   Bognone, Rosemeire A V ^b   Fattori, André ^b   Lorand Metze, Irene ^a   Lima, Carmen S P ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; CD68 ANTIGEN; CYTARABINE; DAUNORUBICIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1 OP; HYDROXYUREA; TIOGUANINE; UNCLASSIFIED DRUG;

ARTICLE; BLAST CELL; BLOOD ANALYSIS; CASE REPORT; CHILD; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME TRANSLOCATION 6; CHROMOSOME TRANSLOCATION 8; CHRONIC MYELOID NEOPLASM; FEMALE; FUSION GENE; HUMAN; HYPERPLASIA; KARYOTYPE 46,XX; LEUKOCYTOSIS; LYMPHADENOPATHY; METAPHASE CHROMOSOME; MYELODYSPLASTIC SYNDROME; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SPLENOMEGALY;

CHILD; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA VERA; TRANSLOCATION, GENETIC;

EID: 52349091550     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802163347     Document Type: Article

References (18)

1. MacDonald, D., Aguiar, R CT, Mason, P. J., Goldman, J. M. and Cross, N CP (1995) A new myeloproliferative disorder associated with chromosome translocation involving 8p11: A review. Leukemia, 10, pp. 1628-1630.
2. Inhorn, R. C., Aster, J. C., Roach, S. A., Slapak, C. A., Soiffer, R. Tantravahi, R. et al. (1995) A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): Description of a distinctive clinicopathologic entity. Blood, 85, pp. 1881-1887.
3. Macdonald, D., Reiter, A. and Cross, N CP (2002) The 8p11 myeloproliferative syndrome: A distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol, 107, pp. 101-107.
4. Belloni, E., Trubia, M., Gasparini, P., Micucci, C., Tapinassi, C. Confalonieri, S. et al. (2005) 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes. Genes Chromosomes Cancer, 42, pp. 320-325.
5. Grand, E. K., Grand, F. H., Chase, A. J., Ross, F. M., Corcoran, M. M. Oscier, D. G. et al. (2004) Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer, 40, pp. 78-83.
6. Hidalgo-Curtis, C., Chase, A., Drachenberg, M., Roberts, M. W., Finkelstein, J. Z. Mould, S. et al. (2008) The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes Chromosomes Cancer, 47, pp. 379-385.
7. Walz, C., Chase, A., Schoch, C., Weisser, A., Schlegel, F. Hochhaus, A. et al. (2005) The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1. Leukemia, 19, pp. 1005-1009.
8. Guasch, G., Popovici, C., Mugneret, F., Chaffanet, M., Pontarotti, P. Birnbaum, D. et al. (2003) Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood, 101, pp. 286-288.
9. Macdonald, D. and Cross, N. C. (2007) Chronic myeloproliferative disorders: The role of tyrosine kinases in pathogenesis, diagnosis and therapy. Pathobiology, 74, pp. 81-88.
10. Vannier, J. P., Bizet, M., Bastard, A., Ducastelle, T. and Tron, P. (1984) Simultaneous occurrence of a T-cell lymphoma and a chronic myelogenous leukaemia with an unusual karyotype. Leuk Res, 8, pp. 647-657.
11. Elsner, S., Martin, H., Rode, C., Wassmann, B., Ganser, A. and Hoelzer, D. (1994) An uncommon translocation t(6;8) associated with atypical acute myeloid leukaemia myeloproliferative disease detected by fluorescence in-situ hybridization. Br J Haematol, 87, p. 124.
12. Chaffanet, M., Popovici, C., Leroux, D., Jacrot, M., Adelaide, J. Dastugue, N. et al. (1998) t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12. Oncogene, 16, pp. 945-949.
13. Sohal, J., Chase, A., Mould, S., Corcoran, M., Oscier, D. Iqbal, S. et al. (2001) Identification of four new translocations involving FGFRI in myeloid disorders. Genes Chromosomes Cancer, 32, pp. 155-163.
14. Popovici, C., Zhang, B., Gregoire, M. J., Jonveaux, P., Lafage-Pochitaloff, M. Birnbaum, D. et al. (1999) The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood, 93, pp. 1381-1389.
15. Vizmanos, J. L., Hernandez, R., Vidal, M. J., Larrayoz, M. J., Odero, M. D. Marin, J. et al. (2004) Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: Two further cases. Hematol J, 5, pp. 534-537.
16. Tefferi, A. and Vardiman, J. W. (2008) Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia, 22, pp. 14-22.
17. Pierre, R., Imbert, M. and Thiele, J. (2001) Polycythaemia vera. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, pp. 32-34. IARC Press, Lyon
18. Monte-Mor, B CR, Cunha, A. F., Pagnano, K BB, Saad, S TO, Lorand-Metze, I. and Costa, F. F. (2007) JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia. Genetics Mol Biol, 30, pp. 336-338.